ARCHIVES

Study: Vismodegib Effective Where Surgery is Inappropriate

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Pazdur to direct FDA Oncology Division; Ganz Awarded ACS Clinical Professorship

July 23, 1999

Unique Molecular Profile For Lung Cancer Described

March 31, 2006

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

In Brief: Resolution Seeks Two-Fold Increase For NIH; Hartwell Named President At Fred Hutchinson

January 31, 1997

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

Limb-Sparing Surgery May Not Offer Better Quality of Life

August 28, 2009